AI

By Dave Muoio 04:01 pm April 26, 2019
Healthcare has long had an access issue. While some patients might have the knowledge, experience and opportunity to pursue optimal care when they’re ill, countless others are unaware of the whens, whys and hows of seeking and receiving relief for their condition.  “Access is really key. That can be access to an appointment to a provider [and] it’s also access to quality information,” Dr. Erin...
By Dave Muoio 03:21 pm April 25, 2019
The last couple of months saw a pair of regulatory clearances from mobile ECG maker AliveCor surface on the FDA’s 510(k) premarket notification database — the first in March for something called KardiaAI, and the latter a dual-update for the company’s existing KardiaMobile and KardiaStation platforms for consumer and point-of-care use. With AliveCor keeping mum at the time, MobiHealthNews...

Photo credit: Cardiogram 

By Laura Lovett 10:00 am April 24, 2019
Today Cardiogram, maker of a smartwatch app that uses a deep neural network technology to detect various heart conditions, announced that it has cut a deal with Oscar Health — the first such healthcare insurer agreement for the startup.  As part of the new agreement, Oscar Health members will be able to enter their insurance information and then download the Cardiogram app. While the Cardiogram...
By Dave Muoio 03:38 pm April 18, 2019
Door closes on drug discovery. IBM is tapering off sales of its Watson for Drug Discovery product in favor of other healthcare offerings using the AI technology, STAT reported this morning. The decision was made in response to weak demand and purchases from customers. "We are focusing our resources within Watson Health to double down on the adjacent field of clinical development where we see an...
By Dave Muoio 11:28 am April 18, 2019
Yesterday PathAI, a Boston-based maker of artificial intelligence tools for pathology, closed a $60 million Series B funding round led by General Atlantic. Other existing investors, most notably General Catalyst, also participated in the round. To monitor its investment, General Atlantic Managing Director Dr. Michelle Dipp will also be joining the AI company’s board of directors. WHAT THEY DO...

Credit: Aidoc

By Dean Koh 03:16 am April 18, 2019
Aidoc, an Israel-based provider of AI solutions for radiologists, announced that it has raised $27M, bringing its total funding to $40M. The Series B round, led by Square Peg Capital, will be used to grow Aidoc's technology and go-to-market team to support the high market demand for its products. The funding comes as Aidoc announced that it has analysed its millionth patients CT scan in real-time...
By Dave Muoio 01:58 pm April 10, 2019
VR cardiac care training. Healthcare training and education firm Health Scholars has launched a VR training simulation to help clinicians practice their advanced cardiac life support (ACLS) skills. The app was built to follow the American Heart Association’s guidelines and programs and incorporates a voice recognition component. “Our mission is to improve patient safety, and by virtualizing ACLS...
By Laura Lovett 09:26 am April 9, 2019
The stakes are high when it comes to implementing artificial intelligence in healthcare, Massachusetts Governor Charlie Baker reminded the audience at the World Medical Innovation Forum in Boston yesterday.  While the technology has the ability to shape the future of health, Baker — who previously served as the CEO of Harvard Pilgrim Health Care — urged the industry to be mindful about data...
By Dave Muoio 01:04 pm April 8, 2019
Deep Lens, a digital pathology startup particularly focused on cancer trials, has brought in a $13.65 million Series A round, according to an SEC filing. The fundraise was headed by Northpond Ventures with additional support from prior investors Rev1 Ventures, Sierra Ventures and Tamarind-Hill Partners, according to a release. The Series A comes quickly after a seed funding round that raised just...
By Jonah Comstock 01:16 pm April 3, 2019
FDA Commissioner Dr. Scott Gottlieb may be stepping down, but he isn’t slowing down on his way out the door. Yesterday the agency dropped a 20-page exploratory whitepaper on how it could address artificial intelligence and machine learning algorithms. “As algorithms evolve, the FDA must also modernize our approach to regulating these products,” Gottlieb wrote in a statement. “We must ensure that...